Roubaix Capital »

Peregrine Pharmaceuticals shares owned by Roubaix Capital

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Roubaix Capital from 13F filings

Historical chart of Roubaix Capital investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Roubaix Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Roubaix Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4M 369k 6.50
2023-09-30 $735k 78k 9.44
2019-03-31 $2.1M 489k 4.25